2019年20个PEPFAR支持的撒哈拉以南非洲国家HIV检测的性别差异
多数国家女性病例发现高于男性,但男性阳性率(4.7%)略高于女性(4.1%)。医疗机构PITC发现约三分之二新病例,但指示检测阳性率最高。
要点
- 多数国家女性HIV病例发现数高于男性,但男性阳性率更高
- 医疗机构PITC发现约三分之二新病例
- 指示检测在所有国家两性中阳性率最高
核心结论
- 多数国家女性HIV病例发现高于男性,但男性阳性率略高,需针对男性优化检测策略以缩小覆盖差距。
主要发现
- 多数国家女性HIV病例发现高于男性。
- 男性阳性率4.7%,女性阳性率4.1%。
- 医疗机构PITC发现约三分之二新病例。
- 指示检测在所有国家两性中阳性率最高。
- VCT和移动检测的产出因性别和国家而异。
临床怎么用
- 应识别并实施最高效的HIV病例发现策略以缩小覆盖差距。
- 检测策略可能需要针对在多数HIV检测项目中代表性不足的男性进行定制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Despite progress toward controlling the human immunodeficiency virus (HIV) epidemic, testing gaps remain, particularly among men and young persons in sub-Saharan Africa (1). This observational study used routinely collected programmatic data from 20 African countries reported to the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) from October 2018 to September 2019 to assess HIV testing coverage and case finding among adults (defined as persons aged ≥15 years). Indicators included number of HIV tests conducted, number of HIV-positive test results, and percentage positivity rate. Overall, the majority of countries reported higher HIV case finding among women than among men. However, a slightly higher percentage positivity was recorded among men (4.7%) than among women (4.1%). Provider-initiated counseling and testing (PITC) in health facilities identified approximately two thirds of all new cases, but index testing had the highest percentage positivity in all countries among both sexes. Yields from voluntary counseling and testing (VCT) and mobile testing varied by sex and by country. These findings highlight the need to identify and implement the most efficient strategies for HIV case finding in these countries to close coverage gaps. Strategies might need to be tailored for men who remain underrepresented in the majority of HIV testing programs.
引用
- Drammeh B, Medley A, Dale H, et al. Sex Differences in HIV Testing - 20 PEPFAR-Supported Sub-Saharan African Countries, 2019. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33270608. doi:10.15585/mmwr.mm6948a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。